Question Time AU

Bill Debate · Second Reading

Australian Centre for Disease Control Bill 2025, Australian Centre for Disease Control (Consequential Amendments and Transitional Provisions) Bill 2025; Second Reading

House of Representatives · Thursday 9 October 2025

Continued from Wednesday 8 October 2025.

Official Hansard for this day (APH) · Read this debate on OpenAustralia

At a glance

Members debated the establishment of an independent Australian Centre for Disease Control to improve pandemic preparedness and public health coordination. Government members supported the bill as a necessary response to pandemic lessons, while the National Party and Opposition opposed it due to concerns over transparency, excessive bureaucratic power, and the exclusion of chronic disease prevention. Independent and Greens members welcomed the agency but raised issues regarding leadership independence, scope limitations, and the need for explicit climate change mandates. The debate concluded without a final vote being recorded in the provided transcripts.

Summary in reported speech - not a transcript. AI-generated, so check the official record before quoting.

How the debate unfolded

Continued the debate

Claydon supported the bill, arguing it addresses legitimate concerns about transparency and data privacy by embedding these protections into the legislation. Claydon emphasised that the agency would operate independently, with mandatory publication of advice and an advisory council including Aboriginal and Torres Strait Islander representation. Claydon highlighted the need for sustained funding and staffing to ensure the agency's credibility and effectiveness. Claydon argued the bill provides a national backbone for health responses, preventing the fragmented and confused approach seen during the COVID-19 pandemic. Claydon urged members to support the bill to honour lessons from past health crises and ensure future preparedness.

Opposition response

Birrell stated the coalition was not opposed to the concept of a disease control centre but opposed the specific legislation due to lack of scrutiny. Birrell argued the bill transferred significant powers from the Chief Medical Officer to bureaucrats and amended the Freedom of Information Act and Biosecurity Act in ways that reduced transparency. Birrell highlighted concerns that the director-general could withhold information and override privacy protections, urging a full Senate inquiry before passage.